Cancer Control Journal

This peer-reviewed journal contains articles on the spectrum of actions and approaches needed to reduce the impact of human malignancy.

 September / October 1997


Guest Editorial: Leukemia — A Transition From Basic Science to Clinical Practice
Lynn C. Moscinski, MD


Cytogenetic and Molecular Evaluation in Myelodysplastic Syndrome and in Acute and Chronic Leukemia
Peter R. Papenhausen, PhD, Lynn C. Moscinski, MD, and Cameron G. Binnie, PhD

Therapeutic Options in the Management of Acute Myelogenous Leukemia in Adults
Ruben A. Saez, MD

Leukemia Support Groups: How Are They Doing?
Donna Corwin Moss, MA, CSW

A Primer for Evaluating Clinical Trials
Gary H. Lyman, MD, MPH, and Nicole M. Kuderer

Polypharmacy in the Older Patient With Cancer
Mary E. Corcoran, RPh, CRPh


Imaging in Oncology: Gallium Scanning as a Prognostic Indicator in Lymphoma
Claudia G. Berman, MD

Cancer Economics: Enhancing Cancer Care and Clinical Trials — New Paradigms for Success
Robert Comis, MD, and Andrew Kelahan, PhD

Infections in Oncology: Toxoplasmic Lymphadenopathy Clinically Presenting as Lymphoma
Eva S. Quiroz, MD, Dominic M. Castellano, BS, John N. Greene, MD, et al

Clinical Research Protocols for Leukemia and Myelodysplastic Syndrome
Margaret Gross-King, RN, MS, OCN

Ten Best Readings on Leukemia
Lynn C. Moscinski, MD

Pathology Update: Diagnostic Pitfalls in Aspiration Biopsy Cytology of Papillary Breast Lesions
Ni Ni K. Ku, MD, Nancy Mela, CT (ASCP), Charles E. Cox, MD, et al

Internet Sites for the Physician
Linda Splawn, MS, MA, and Linda Stenglein

Letters to the Editor



The pretest and posttest of this issue of Cancer Control is graced by Kevin (Joseph Gallagher), ca 1928, by Robert Henri (1865-1929). Gift of Mrs Marion Peel Calhoun in memory of Mr and Mrs William Lawson Peel and William Lawson Peel, Jr. Courtesy of the High Museum of Art, Atlanta, Ga.